| RS2107939877 |
UBA5
|
Health Risk |
Pathogenic |
— |
| RS2107943571 |
PDHB
|
Health Risk |
Likely pathogenic |
Pyruvate dehydrogenase E1-beta deficiency, Pyruvate dehydrogenase E1-beta deficiency |
| RS2107943727 |
UBA5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 44 |
| RS2107950178 |
UBA5
|
Health Risk |
Pathogenic |
— |
| RS2107951359 |
CLRN1
|
Health Risk |
Pathogenic |
— |
| RS2107952051 |
DAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9 |
| RS2107961294 |
NPHP3
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS2107963367 |
NPHP3
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS2107963405 |
NPHP3
|
Health Risk |
Likely pathogenic |
Enlarged kidney, Multiple renal cysts |
| RS2107971687 |
NPHP3
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS2107974557 |
NPHP3
|
Health Risk |
Likely pathogenic |
Enlarged kidney, Multiple renal cysts |
| RS2107974888 |
MYLK
|
Health Risk |
Pathogenic |
Aortic aneurysm, familial thoracic 7 |
| RS2107975487 |
AGTR1
|
Health Risk |
Likely pathogenic |
Essential hypertension, genetic |
| RS2107975850 |
AGTR1
|
Health Risk |
Likely pathogenic |
Renal tubular dysgenesis, Renal tubular dysgenesis |
| RS2107976854 |
NPHP3
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS2107977736 |
ARL6
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 3, Retinitis pigmentosa 55 |
| RS2107990671 |
NPHP3
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS2107994263 |
ZIC1
|
Health Risk |
Likely pathogenic |
Structural brain anomalies with impaired intellectual development and craniosynostosis, Structural brain anomalies with impaired intellectual development and craniosynostosis |
| RS2107996325 |
NPHP3
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS2107996885 |
CLRN1
|
Health Risk |
Pathogenic |
— |
| RS2108006223 |
MYLK
|
Health Risk |
Likely pathogenic |
Aortic aneurysm, familial thoracic 7 |
| RS2108007892 |
NPHP3
|
Health Risk |
Likely pathogenic |
Joubert syndrome and related disorders, Joubert syndrome and related disorders |
| RS2108008280 |
NPHP3
|
Health Risk |
Likely pathogenic |
Joubert syndrome and related disorders, Joubert syndrome and related disorders |
| RS2108009356 |
GFM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Leigh syndrome |
| RS2108009467 |
GFM1
|
Health Risk |
Pathogenic |
— |
| RS2108009622 |
GFM1
|
Health Risk |
Pathogenic |
— |
| RS2108010958 |
PLOD2
|
Health Risk |
Pathogenic |
— |
| RS2108010991 |
PLOD2
|
Health Risk |
Pathogenic |
— |
| RS2108014903 |
PLCH1
|
Health Risk |
Pathogenic |
Holoprosencephaly 14, Holoprosencephaly 14 |
| RS2108016910 |
GFM1
|
Health Risk |
Likely pathogenic |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
| RS2108017010 |
GFM1
|
Health Risk |
Pathogenic |
— |
| RS2108018519 |
GFM1
|
Health Risk |
Likely pathogenic |
— |
| RS2108023364 |
GFM1
|
Health Risk |
Pathogenic |
— |
| RS2108033397 |
ATP6V1A
|
Health Risk |
Likely pathogenic |
Encephalopathy, Developmental and epileptic encephalopathy 93 |
| RS2108034196 |
ATP6V1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 93, Developmental and epileptic encephalopathy 93 |
| RS2108035368 |
SLCO2A1
|
Health Risk |
Pathogenic |
Hypertrophic osteoarthropathy, primary |
| RS2108035416 |
GFM1
|
Health Risk |
Pathogenic |
— |
| RS2108035662 |
GFM1
|
Health Risk |
Pathogenic |
— |
| RS2108041578 |
SLCO2A1
|
Health Risk |
Pathogenic |
— |
| RS2108043577 |
SLCO2A1
|
Health Risk |
Pathogenic |
Hypertrophic osteoarthropathy, primary |
| RS2108044392 |
GFM1
|
Health Risk |
Pathogenic |
— |
| RS2108045784 |
SLCO2A1
|
Health Risk |
Likely pathogenic |
Hypertrophic osteoarthropathy, primary |
| RS2108045848 |
SLCO2A1
|
Health Risk |
Likely pathogenic |
Hypertrophic osteoarthropathy, primary |
| RS2108051038 |
GFM1
|
Health Risk |
Likely pathogenic |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
| RS2108053298 |
GFM1
|
Health Risk |
Pathogenic |
— |
| RS2108053490 |
GFM1
|
Health Risk |
Pathogenic |
— |
| RS2108053962 |
ARL6
|
Health Risk |
Likely pathogenic |
Abnormality of the eye, Retinitis pigmentosa 55 |
| RS2108057452 |
PLOD2
|
Health Risk |
Pathogenic |
Bruck syndrome 2, Bruck syndrome 2 |
| RS2108073043 |
ROBO1
|
Health Risk |
Likely pathogenic |
Congenital anomaly of kidney and urinary tract, Congenital anomaly of kidney and urinary tract |
| RS2108083606 |
ZBTB20
|
Health Risk |
Likely pathogenic |
Primrose syndrome, Primrose syndrome |
| RS2108086458 |
ELP6
|
Health Risk |
Likely pathogenic |
— |
| RS2108101855 |
IFT122
|
Health Risk |
Likely pathogenic |
Cranioectodermal dysplasia 1, Cranioectodermal dysplasia 1 |
| RS2108102423 |
GFM1
|
Health Risk |
Likely pathogenic |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
| RS2108102433 |
GFM1
|
Health Risk |
Pathogenic |
— |
| RS2108102670 |
GFM1
|
Health Risk |
Pathogenic |
— |
| RS2108111799 |
HPS3
|
Health Risk |
Pathogenic |
— |
| RS2108112355 |
MYLK
|
Health Risk |
Likely pathogenic |
Aortic aneurysm, familial thoracic 7 |
| RS2108112398 |
HPS3
|
Health Risk |
Pathogenic |
— |
| RS2108112449 |
HPS3
|
Health Risk |
Pathogenic |
— |
| RS2108112474 |
HPS3
|
Health Risk |
Pathogenic |
— |
| RS2108127087 |
SI
|
Health Risk |
Pathogenic |
— |
| RS2108127602 |
PCCB
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2108127864 |
HPS3
|
Health Risk |
Pathogenic |
— |
| RS2108127935 |
PCCB
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2108128051 |
PCCB
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2108128131 |
PCCB
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2108128163 |
PCCB
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2108128892 |
HPS3
|
Health Risk |
Pathogenic |
— |
| RS2108128944 |
HPS3
|
Health Risk |
Pathogenic |
— |
| RS2108129745 |
HPS3
|
Health Risk |
Likely pathogenic |
— |
| RS2108129931 |
HPS3
|
Health Risk |
Pathogenic |
— |
| RS2108129996 |
HPS3
|
Health Risk |
Pathogenic |
— |
| RS2108130124 |
HPS3
|
Health Risk |
Pathogenic |
— |
| RS2108137253 |
PCCB
|
Health Risk |
Pathogenic/Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2108138101 |
HPS3
|
Health Risk |
Pathogenic |
— |
| RS2108144374 |
PCCB
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2108144496 |
PCCB
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2108146606 |
PCCB
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2108146615 |
PCCB
|
Health Risk |
Pathogenic/Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2108146780 |
PCCB
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2108146835 |
PCCB
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2108146990 |
HPS3
|
Health Risk |
Pathogenic |
— |
| RS2108147274 |
HPS3
|
Health Risk |
Likely pathogenic |
— |
| RS2108148749 |
ADCY5
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with hyperkinetic movements and dyskinesia, Neurodevelopmental disorder with hyperkinetic movements and dyskinesia |
| RS2108152614 |
HPS3
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS2108152647 |
HPS3
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS2108155359 |
HPS3
|
Health Risk |
Pathogenic |
— |
| RS2108157679 |
PLOD2
|
Health Risk |
Pathogenic |
Bruck syndrome 2, Bruck syndrome 2 |
| RS2108158577 |
HPS3
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS2108168417 |
HPS3
|
Health Risk |
Pathogenic |
— |
| RS2108170158 |
HPS3
|
Health Risk |
Likely pathogenic |
— |
| RS2108173648 |
HPS3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS2108175642 |
SI
|
Health Risk |
Likely pathogenic |
— |
| RS2108182082 |
PCCB
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2108182735 |
TERC
|
Health Risk |
Likely risk allele |
Pulmonary fibrosis, Pulmonary fibrosis |
| RS2108182738 |
TERC
|
Health Risk |
Likely risk allele |
Pulmonary fibrosis, Pulmonary fibrosis |
| RS2108183105 |
TERC
|
Health Risk |
Pathogenic |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS2108183177 |
SI
|
Health Risk |
Likely pathogenic |
— |
| RS2108183267 |
TERC
|
Health Risk |
Likely pathogenic |
TERC-related disorder, TERC-related disorder |
| RS2108183554 |
TERC
|
Health Risk |
Likely pathogenic |
— |